HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Aaron D Bossler Selected Research
Aaron D Bossler Research Topics
Disease
11
Neoplasms (Cancer)
04/2024 - 09/2006
8
Melanoma (Melanoma, Malignant)
01/2022 - 10/2017
3
Neoplasm Metastasis (Metastasis)
03/2021 - 10/2020
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2022
2
Glioma (Gliomas)
01/2019 - 01/2019
2
Thyroid Neoplasms (Thyroid Cancer)
01/2019 - 01/2018
2
Lung Neoplasms (Lung Cancer)
01/2018 - 09/2015
1
Brain Neoplasms (Brain Tumor)
03/2021
1
Glycogen Storage Disease Type VI (Glycogenosis Type VI)
01/2021
1
Colorectal Neoplasms (Colorectal Cancer)
01/2020
1
Disease Progression
12/2019
1
Lymphopenia (Lymphocytopenia)
12/2019
1
Carcinoma (Carcinomatosis)
01/2019
1
Muscle Hypotonia (Hypotonia)
01/2018
1
Muscular Dystrophies (Muscular Dystrophy)
01/2018
1
Adenocarcinoma of Lung
01/2018
1
Fatigue
10/2017
1
Neutropenia
10/2017
1
Hyperuricemia
10/2017
1
Hypophosphatemia
10/2017
1
Exanthema (Rash)
10/2017
1
Sarcoma (Soft Tissue Sarcoma)
07/2016
1
Cystic Fibrosis (Mucoviscidosis)
06/2012
1
Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2009
1
Papilloma (Papillomatosis)
08/2009
1
Condylomata Acuminata (Genital Wart)
08/2009
1
Recurrent respiratory papillomatosis
08/2009
1
Infections
08/2009
1
Squamous Cell Carcinoma of Head and Neck
02/2008
1
Hypotension (Low Blood Pressure)
09/2006
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2006
1
Nausea
09/2006
1
Lymphoma (Lymphomas)
09/2006
Drug/Important Bio-Agent (IBA)
3
pembrolizumab
IBA
01/2021 - 01/2019
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2023 - 01/2018
2
ErbB Receptors (EGF Receptor)
IBA
01/2023 - 01/2018
2
RNA (Ribonucleic Acid)
IBA
01/2018 - 07/2016
2
Proteins (Proteins, Gene)
FDA Link
01/2018 - 02/2008
1
epidermal growth factor receptor VIII
IBA
04/2024
1
mobocertinib
IBA
01/2023
1
amivantamab-vmjw
IBA
01/2023
1
DNA (Deoxyribonucleic Acid)
IBA
01/2022
1
Platinum
IBA
01/2022
1
Trabectedin
IBA
01/2021
1
pazopanib
FDA Link
01/2021
1
S100 Proteins (S 100 Protein)
IBA
01/2021
1
Tyrosine Kinase Inhibitors
IBA
01/2021
1
Albumins
IBA
10/2020
1
Anti-Bacterial Agents (Antibiotics)
IBA
10/2020
1
Temozolomide (Temodar)
FDA Link
Generic
12/2019
1
Nivolumab
IBA
01/2019
1
trametinib
IBA
01/2019
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2019
1
Chemokines
IBA
01/2018
1
Creatine Kinase (Creatine Phosphokinase)
IBA
01/2018
1
Anaplastic Lymphoma Kinase
IBA
01/2018
1
Nucleic Acids
IBA
01/2018
1
Nucleotides
IBA
01/2018
1
Dystroglycans (Dystroglycan)
IBA
01/2018
1
Vemurafenib
IBA
10/2017
1
Decitabine
FDA Link
10/2017
1
Creatinine
IBA
10/2017
1
Smoke
IBA
09/2015
1
Enzymes
IBA
09/2015
1
Carcinogens
IBA
09/2015
1
Cytokines
IBA
08/2009
1
Interferons
IBA
08/2009
1
CPG-oligonucleotide
IBA
09/2006
1
ProMune (CpG 7909)
IBA
09/2006
1
Oligodeoxyribonucleotides
IBA
09/2006
Therapy/Procedure
14
Therapeutics
01/2023 - 09/2006
5
Immunotherapy
01/2022 - 01/2018
1
Drug Therapy (Chemotherapy)
01/2022
1
Radiotherapy
03/2021
1
Lasers (Laser)
06/2012
1
Intravenous Infusions
09/2006
1
Catheters
09/2006